BUPROPION HYDROCHLORIDE

BUPROPION HYDROCHLORIDE was reported 99465 times

BUPROPION HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TEMPERATURE REGULATION DISORDER 513 0.2300
1 EJECTION FRACTION 103 0.1773
2 STOOL ANALYSIS ABNORMAL 67 0.1768
3 SENSITISATION 121 0.1594
4 RETINITIS 184 0.1064
5 POLYCYSTIC OVARIES 138 0.0889
6 FOOD ALLERGY 641 0.0830
7 JOINT DESTRUCTION 123 0.0790
8 POSTICTAL STATE 82 0.0789
9 RHEUMATOID FACTOR POSITIVE 419 0.0725
10 LUPUS VULGARIS 86 0.0683
11 OESOPHAGEAL SPASM 118 0.0640
12 OBSTRUCTIVE SLEEP APNOEA SYNDROME 93 0.0637
13 BONE EROSION 219 0.0619
14 FOETAL DEATH 311 0.0599
15 LIBIDO INCREASED 115 0.0567
16 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 129 0.0559
17 PRE-EXISTING CONDITION IMPROVED 341 0.0546
18 COELIAC DISEASE 534 0.0544
19 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 275 0.0536
20 IMMUNODEFICIENCY 792 0.0531
21 HOSTILITY 131 0.0515
22 GAMBLING DISORDER 134 0.0496
23 GRAND MAL CONVULSION 458 0.0496
24 HALLUCINATIONS, MIXED 205 0.0487
25 BURSITIS 571 0.0470
26 TONGUE BITING 95 0.0460
27 MEDICATION RESIDUE 118 0.0457
28 PRODUCT ODOUR ABNORMAL 466 0.0444
29 PSYCHIATRIC DECOMPENSATION 85 0.0435
30 DRUG TOLERANCE 218 0.0430
31 RHINITIS ALLERGIC 188 0.0422
32 DIABETIC NEUROPATHY 208 0.0420
33 SLEEP APNOEA SYNDROME 796 0.0417
34 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 298 0.0416
35 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 168 0.0404
36 DEPRESSIVE SYMPTOM 139 0.0394
37 DRUG SCREEN FALSE POSITIVE 109 0.0394
38 COMPULSIVE SHOPPING 80 0.0389
39 MAJOR DEPRESSION 278 0.0380
40 FOOT DEFORMITY 416 0.0375
41 TEARFULNESS 161 0.0374
42 PRESCRIBED OVERDOSE 714 0.0369
43 OBESITY 567 0.0356
44 BIPOLAR I DISORDER 78 0.0355
45 CONTRAINDICATED PRODUCT ADMINISTERED 1069 0.0353
46 DEPRESSION SUICIDAL 122 0.0352
47 WHITE BLOOD CELL COUNT ABNORMAL 223 0.0349
48 IMPATIENCE 64 0.0340
49 ANORGASMIA 92 0.0339
50 PRODUCT ADMINISTRATION INTERRUPTED 265 0.0337
51 IMPULSE-CONTROL DISORDER 69 0.0335
52 CHOLECYSTITIS CHRONIC 222 0.0331
53 TACHYPHRENIA 114 0.0329
54 INFARCTION 225 0.0328
55 DIABETIC COMA 91 0.0325
56 BIPOLAR DISORDER 353 0.0324
57 EXOSTOSIS 296 0.0324
58 FLAT AFFECT 75 0.0324
59 POST-TRAUMATIC STRESS DISORDER 213 0.0317
60 PERSONALITY DISORDER 83 0.0317
61 SEROTONIN SYNDROME 608 0.0316
62 FIBROMYALGIA 755 0.0310
63 HOMICIDAL IDEATION 122 0.0301
64 SEXUAL DYSFUNCTION 345 0.0294
65 DECREASED INTEREST 173 0.0293
66 CLONUS 80 0.0292
67 FEELING OF DESPAIR 136 0.0291
68 BRUXISM 157 0.0291
69 JOINT DISLOCATION 307 0.0290
70 HYPOMANIA 104 0.0283
71 LOSS OF EMPLOYMENT 85 0.0281
72 SUICIDAL IDEATION 2561 0.0279
73 DEPRESSION 6362 0.0279
74 ENERGY INCREASED 163 0.0276
75 OESOPHAGEAL PAIN 109 0.0276
76 HANGOVER 97 0.0276
77 PSYCHOMOTOR SKILLS IMPAIRED 72 0.0275
78 RED BLOOD CELL SEDIMENTATION RATE INCREASED 301 0.0272
79 CRYING 979 0.0269
80 PARANOIA 464 0.0269
81 THERMAL BURN 190 0.0267
82 TYPE 2 DIABETES MELLITUS 896 0.0266
83 POLYARTHRITIS 140 0.0265
84 CONVULSION 1515 0.0265
85 DRUG SCREEN POSITIVE 208 0.0263
86 OBSESSIVE-COMPULSIVE DISORDER 209 0.0260
87 DYSPHEMIA 113 0.0257
88 SELF-INJURIOUS IDEATION 106 0.0252
89 ANGER 850 0.0251
90 SNORING 95 0.0251
91 DISSOCIATION 192 0.0250
92 MANIA 410 0.0249
93 TINNITUS 1139 0.0248
94 WOUND COMPLICATION 85 0.0247
95 HYPERLIPIDAEMIA 293 0.0245
96 AREFLEXIA 65 0.0243
97 FEELING JITTERY 462 0.0242
98 PRODUCT SUBSTITUTION ISSUE 1393 0.0242
99 ALCOHOLISM 102 0.0238
100 SOMNAMBULISM 154 0.0234
101 TYPE 1 DIABETES MELLITUS 141 0.0234
102 UPPER RESPIRATORY TRACT INFECTION 1070 0.0231
103 SUICIDAL BEHAVIOUR 96 0.0231
104 SYNOVITIS 416 0.0230
105 APATHY 335 0.0229
106 LUPUS-LIKE SYNDROME 207 0.0228
107 INFUSION SITE PRURITUS 72 0.0228
108 HYPERPHAGIA 91 0.0228
109 PRODUCT RESIDUE PRESENT 123 0.0228
110 LYMPHOEDEMA 156 0.0225
111 PANIC ATTACK 820 0.0225
112 HALLUCINATION, AUDITORY 357 0.0224
113 HYPERREFLEXIA 77 0.0221
114 AGITATION 1621 0.0220
115 ENURESIS 89 0.0220
116 NICOTINE DEPENDENCE 171 0.0220
117 IRRITABILITY 1322 0.0220
118 LUMBAR SPINAL STENOSIS 64 0.0219
119 INTENTIONAL OVERDOSE 1390 0.0216
120 THINKING ABNORMAL 402 0.0216
121 RESTLESS LEGS SYNDROME 390 0.0214
122 HAND DEFORMITY 278 0.0212
123 PEMPHIGUS 261 0.0209
124 AFFECTIVE DISORDER 164 0.0208
125 STOMACH DISCOMFORT 107 0.0207
126 CARPAL TUNNEL SYNDROME 288 0.0205
127 SUICIDE ATTEMPT 1241 0.0204
128 SOCIAL AVOIDANT BEHAVIOUR 118 0.0204
129 INITIAL INSOMNIA 209 0.0203
130 INFUSION SITE HAEMORRHAGE 67 0.0203
131 IMPULSIVE BEHAVIOUR 76 0.0202
132 DISTURBANCE IN ATTENTION 1092 0.0202
133 CONCUSSION 155 0.0200
134 ANXIETY 5697 0.0200
135 ECONOMIC PROBLEM 302 0.0199
136 HYPERCHOLESTEROLAEMIA 192 0.0199
137 ANOREXIA 256 0.0198
138 PANIC REACTION 143 0.0198
139 SINUS TACHYCARDIA 281 0.0198
140 INTERVERTEBRAL DISC DEGENERATION 183 0.0198
141 CARDIOGENIC SHOCK 280 0.0195
142 INSURANCE ISSUE 298 0.0195
143 PANIC DISORDER 75 0.0193
144 MUSCLE TWITCHING 446 0.0193
145 VISUAL DISTURBANCE 111 0.0193
146 RHEUMATIC FEVER 86 0.0193
147 GENERALISED TONIC-CLONIC SEIZURE 319 0.0193
148 GLUCOSE TOLERANCE IMPAIRED 114 0.0193
149 SUSPECTED SUICIDE 90 0.0192
150 FOOT OPERATION 95 0.0192
151 PHARMACEUTICAL PRODUCT COMPLAINT 493 0.0190
152 FEELING DRUNK 141 0.0190
153 ALCOHOL USE 70 0.0189
154 BREATH SOUNDS ABNORMAL 92 0.0186
155 TENSION 113 0.0185
156 ABNORMAL DREAMS 512 0.0185
157 INTENTIONAL SELF-INJURY 369 0.0183
158 PHARYNGOLARYNGEAL PAIN 97 0.0182
159 WHEELCHAIR USER 81 0.0182
160 NEPHROGENIC ANAEMIA 84 0.0181
161 DIABETES MELLITUS 1372 0.0180
162 WOUND 502 0.0179
163 MIDDLE INSOMNIA 335 0.0179
164 STATUS EPILEPTICUS 202 0.0179
165 BLOOD TRIGLYCERIDES INCREASED 316 0.0179
166 ATTENTION DEFICIT HYPERACTIVITY DISORDER 75 0.0178
167 HEPATIC ENZYME INCREASED 1211 0.0177
168 HYPERHIDROSIS 2266 0.0176
169 DYSPHORIA 89 0.0176
170 DYSLIPIDAEMIA 89 0.0175
171 INFUSION SITE SWELLING 110 0.0175
172 EUPHORIC MOOD 179 0.0175
173 MENTAL DISORDER 756 0.0174
174 MEDICATION RESIDUE PRESENT 82 0.0172
175 INABILITY TO AFFORD MEDICATION 170 0.0171
176 HYPOTHYROIDISM 546 0.0171
177 INSOMNIA 4541 0.0170
178 PSYCHOLOGICAL TRAUMA 147 0.0170
179 PSYCHOMOTOR HYPERACTIVITY 282 0.0170
180 AFFECT LABILITY 163 0.0169
181 MOOD SWINGS 537 0.0168
182 SPINAL OSTEOARTHRITIS 147 0.0167
183 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 798 0.0166
184 RHEUMATOID ARTHRITIS 1879 0.0165
185 SPINAL COLUMN STENOSIS 78 0.0165
186 BLOOD CHOLESTEROL INCREASED 767 0.0164
187 NIGHTMARE 568 0.0164
188 FLUID RETENTION 834 0.0164
189 PSYCHOTIC DISORDER 483 0.0163
190 TREMOR 2713 0.0163
191 AMNESIA 1055 0.0162
192 DENTAL CARIES 179 0.0162
193 COMPLETED SUICIDE 1345 0.0161
194 PATENT DUCTUS ARTERIOSUS 64 0.0161
195 GASTROENTERITIS VIRAL 291 0.0161
196 IMPAIRED DRIVING ABILITY 183 0.0161
197 ASTHMA 1815 0.0160
198 FULL BLOOD COUNT ABNORMAL 168 0.0159
199 NODULE 207 0.0158
200 RASH ERYTHEMATOUS 758 0.0158
201 GLOSSODYNIA 354 0.0158
202 MIGRAINE 1496 0.0157
203 BRADYPHRENIA 102 0.0156
204 FOOD CRAVING 82 0.0156
205 BRAIN FOG 243 0.0155
206 HEPATIC CIRRHOSIS 288 0.0153
207 THERAPEUTIC RESPONSE UNEXPECTED 685 0.0153
208 SEASONAL ALLERGY 216 0.0152
209 INTERVERTEBRAL DISC DISORDER 65 0.0152
210 SEDATION 396 0.0151
211 FORMICATION 105 0.0151
212 OSTEOARTHRITIS 639 0.0151
213 NERVOUSNESS 786 0.0150
214 TIC 82 0.0150
215 MOOD ALTERED 410 0.0150
216 DEPRESSED MOOD 793 0.0150
217 ANKLE FRACTURE 230 0.0148
218 MYDRIASIS 190 0.0148
219 PERFORMANCE STATUS DECREASED 69 0.0148
220 VENTRICULAR TACHYCARDIA 244 0.0148
221 INCREASED APPETITE 281 0.0147
222 DRY MOUTH 1190 0.0147
223 EXPOSURE DURING PREGNANCY 909 0.0146
224 EMOTIONAL DISORDER 450 0.0146
225 MYOCLONUS 174 0.0146
226 PAROSMIA 110 0.0146
227 MULTIPLE ALLERGIES 114 0.0145
228 TARDIVE DYSKINESIA 407 0.0144
229 PERSONALITY CHANGE 134 0.0144
230 HYPERSOMNIA 413 0.0144
231 FLANK PAIN 135 0.0144
232 THERAPEUTIC PRODUCT EFFECT DECREASED 645 0.0144
233 ANHEDONIA 378 0.0144
234 THERAPEUTIC RESPONSE CHANGED 91 0.0143
235 EAR INFECTION 382 0.0143
236 ERECTILE DYSFUNCTION 367 0.0143
237 PERICARDITIS 240 0.0143
238 HALLUCINATION, VISUAL 300 0.0142
239 DYSKINESIA 573 0.0141
240 ADRENAL INSUFFICIENCY 170 0.0140
241 RETCHING 298 0.0140
242 WEIGHT INCREASED 3126 0.0139
243 HAIR DISORDER 115 0.0139
244 JOINT STIFFNESS 365 0.0139
245 INTERVERTEBRAL DISC PROTRUSION 304 0.0139
246 AKATHISIA 189 0.0138
247 MUSCLE TIGHTNESS 224 0.0138
248 HUNGER 192 0.0138
249 GASTROOESOPHAGEAL REFLUX DISEASE 1109 0.0138
250 VITAMIN D DEFICIENCY 134 0.0137
251 GALLBLADDER DISORDER 245 0.0137
252 MATERNAL DRUGS AFFECTING FOETUS 105 0.0137
253 BLOOD PRESSURE DIASTOLIC INCREASED 63 0.0136
254 HAIR TEXTURE ABNORMAL 182 0.0136
255 OSTEOPOROSIS 559 0.0136
256 LOSS OF LIBIDO 122 0.0136
257 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 228 0.0134
258 POOR QUALITY SLEEP 289 0.0134
259 INFUSION SITE PAIN 172 0.0133
260 FEELING ABNORMAL 3198 0.0133
261 IRRITABLE BOWEL SYNDROME 285 0.0133
262 MEMORY IMPAIRMENT 1826 0.0133
263 IMPAIRED GASTRIC EMPTYING 181 0.0133
264 RESTLESSNESS 485 0.0132
265 IMPAIRED WORK ABILITY 283 0.0132
266 HYSTERECTOMY 114 0.0131
267 TOOTH FRACTURE 145 0.0131
268 FOOT FRACTURE 249 0.0131
269 ELECTROCARDIOGRAM QT PROLONGED 472 0.0131
270 MENISCUS INJURY 80 0.0130
271 WITHDRAWAL SYNDROME 546 0.0130
272 DIABETES MELLITUS INADEQUATE CONTROL 230 0.0130
273 INCONTINENCE 137 0.0129
274 VERTIGO 787 0.0129
275 ROAD TRAFFIC ACCIDENT 540 0.0129
276 ATRIAL SEPTAL DEFECT 108 0.0129
277 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 916 0.0129
278 PULMONARY FIBROSIS 246 0.0128
279 INFUSION RELATED REACTION 848 0.0128
280 HAIR COLOUR CHANGES 159 0.0128
281 SYMPTOM RECURRENCE 76 0.0127
282 ABNORMAL BEHAVIOUR 499 0.0126
283 DRUG INTOLERANCE 1216 0.0126
284 BRONCHITIS 928 0.0125
285 RHINITIS 101 0.0125
286 DIVERTICULUM 89 0.0125
287 DUODENAL ULCER PERFORATION 93 0.0125
288 HYPERTENSION 2635 0.0124
289 OBSTRUCTIVE AIRWAYS DISORDER 138 0.0124
290 METABOLIC DISORDER 72 0.0124
291 SENSITIVITY TO WEATHER CHANGE 65 0.0123
292 BACK INJURY 134 0.0123
293 PARKINSONISM 120 0.0123
294 SCOLIOSIS 76 0.0123
295 RIB FRACTURE 252 0.0122
296 BLOOD TEST ABNORMAL 172 0.0122
297 VENTRICULAR SEPTAL DEFECT 70 0.0122
298 FEAR 328 0.0122
299 CHOLELITHIASIS 399 0.0122
300 AGGRESSION 606 0.0121
301 DELUSION 188 0.0121
302 ROTATOR CUFF SYNDROME 155 0.0121
303 ARTHRITIS 944 0.0120
304 DYSGRAPHIA 79 0.0120
305 MUSCULOSKELETAL STIFFNESS 1049 0.0120
306 SCREAMING 76 0.0119
307 HALLUCINATION 899 0.0119
308 BREAST MASS 80 0.0119
309 HIATUS HERNIA 154 0.0119
310 MENTAL STATUS CHANGES 330 0.0119
311 NERVE COMPRESSION 109 0.0118
312 DERMATITIS CONTACT 134 0.0117
313 ELECTROCARDIOGRAM ABNORMAL 92 0.0117
314 SKIN LACERATION 127 0.0117
315 CARDIAC MURMUR 101 0.0117
316 SENSORY DISTURBANCE 187 0.0116
317 DISORIENTATION 461 0.0116
318 INFUSION SITE ERYTHEMA 98 0.0116
319 SINUS DISORDER 229 0.0116
320 DRUG INTERACTION 1834 0.0115
321 DRUG ABUSER 71 0.0115
322 SLEEP DISORDER 815 0.0115
323 CARDIOTOXICITY 103 0.0115
324 NIGHT SWEATS 371 0.0115
325 APHASIA 347 0.0115
326 NONSPECIFIC REACTION 63 0.0115
327 MENTAL IMPAIRMENT 278 0.0115
328 SYSTEMIC LUPUS ERYTHEMATOSUS 407 0.0115
329 SINUSITIS 1174 0.0114
330 LIGAMENT SPRAIN 113 0.0114
331 BALANCE DISORDER 986 0.0114
332 ATELECTASIS 110 0.0114
333 FACIAL PAIN 101 0.0113
334 ACTIVITIES OF DAILY LIVING IMPAIRED 224 0.0113
335 CHOLECYSTECTOMY 129 0.0113
336 HAEMODYNAMIC INSTABILITY 86 0.0113
337 PRESCRIBED UNDERDOSE 225 0.0113
338 FEELING OF BODY TEMPERATURE CHANGE 66 0.0112
339 HEADACHE 7059 0.0112
340 TEMPERATURE INTOLERANCE 116 0.0112
341 EATING DISORDER 239 0.0112
342 BODY HEIGHT DECREASED 120 0.0112
343 MUSCLE STRAIN 97 0.0112
344 IMPAIRED QUALITY OF LIFE 161 0.0112
345 COORDINATION ABNORMAL 156 0.0112
346 BRAIN INJURY 112 0.0112
347 INCOHERENT 72 0.0111
348 CEREBRAL DISORDER 82 0.0111
349 VENTRICULAR EXTRASYSTOLES 115 0.0111
350 LACERATION 104 0.0110
351 LETHARGY 636 0.0110
352 MICTURITION URGENCY 126 0.0110
353 SEIZURE 1274 0.0110
354 INJURY 774 0.0110
355 BACK DISORDER 179 0.0110
356 VITAMIN D DECREASED 94 0.0110
357 MENSTRUAL DISORDER 91 0.0110
358 SOMNOLENCE 2211 0.0110
359 SINUS CONGESTION 148 0.0109
360 HEPATIC STEATOSIS 204 0.0109
361 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
362 URINE ODOUR ABNORMAL 64 0.0109
363 HAND FRACTURE 77 0.0109
364 APPETITE DISORDER 72 0.0108
365 STAPHYLOCOCCAL INFECTION 358 0.0108
366 DYSARTHRIA 407 0.0108
367 PELVIC PAIN 196 0.0108
368 HYPERSENSITIVITY 2001 0.0108
369 SINUS HEADACHE 64 0.0108
370 CYSTITIS 340 0.0107
371 APNOEA 83 0.0107
372 ARTHROPOD BITE 79 0.0106
373 TREATMENT NONCOMPLIANCE 583 0.0106
374 COGNITIVE DISORDER 497 0.0106
375 ALOPECIA 2086 0.0106
376 TOOTHACHE 192 0.0106
377 URINARY INCONTINENCE 313 0.0106
378 ARTHROPATHY 587 0.0106
379 HEAD INJURY 334 0.0105
380 NOCTURIA 128 0.0105
381 VISION BLURRED 1446 0.0105
382 EMPHYSEMA 106 0.0105
383 OSTEOPENIA 159 0.0105
384 SPUTUM DISCOLOURED 99 0.0104
385 CONSTIPATION 2276 0.0104
386 INCREASED TENDENCY TO BRUISE 96 0.0104
387 PSYCHIATRIC SYMPTOM 77 0.0104
388 JOINT SWELLING 1257 0.0104
389 SCIATICA 166 0.0104
390 CHOLECYSTITIS 124 0.0104
391 INTENTIONAL PRODUCT USE ISSUE 911 0.0104
392 LIMB DISCOMFORT 321 0.0104
393 EAR DISCOMFORT 106 0.0103
394 SUBSTANCE ABUSE 84 0.0103
395 HELICOBACTER INFECTION 106 0.0103
396 NEURALGIA 250 0.0103
397 DIZZINESS 5119 0.0103
398 KNEE ARTHROPLASTY 214 0.0102
399 UTERINE LEIOMYOMA 74 0.0101
400 BLOOD TESTOSTERONE DECREASED 69 0.0101
401 RENAL CYST 80 0.0101
402 DRUG ADMINISTRATION ERROR 309 0.0101
403 NECK PAIN 562 0.0100
404 DISABILITY 198 0.0100
405 EMBEDDED DEVICE 99 0.0100
406 POLLAKIURIA 416 0.0100
407 INFUSION SITE EXTRAVASATION 62 0.0100
408 DRUG EXPOSURE DURING PREGNANCY 338 0.0099
409 NAUSEA 7850 0.0099
410 DECREASED IMMUNE RESPONSIVENESS 97 0.0099
411 TRICUSPID VALVE INCOMPETENCE 78 0.0098
412 SLUGGISHNESS 100 0.0098
413 THIRST 175 0.0098
414 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 509 0.0097
415 HYPERAESTHESIA 80 0.0097
416 CONFUSIONAL STATE 1570 0.0097
417 SCAR 166 0.0097
418 SPEECH DISORDER 508 0.0097
419 CARDIOMEGALY 119 0.0097
420 BLADDER DISORDER 96 0.0097
421 C-REACTIVE PROTEIN ABNORMAL 62 0.0097
422 WRONG TECHNIQUE IN DRUG USAGE PROCESS 351 0.0097
423 INADEQUATE ANALGESIA 82 0.0096
424 AUTOIMMUNE DISORDER 94 0.0096
425 LOSS OF CONSCIOUSNESS 1233 0.0096
426 TENDERNESS 100 0.0096
427 LIVE BIRTH 80 0.0096
428 WEIGHT FLUCTUATION 100 0.0095
429 TONGUE DISORDER 69 0.0095
430 ENCEPHALOPATHY 234 0.0095
431 TREATMENT FAILURE 789 0.0095
432 HYPOAESTHESIA 1425 0.0095
433 EAR PAIN 185 0.0095
434 DRUG WITHDRAWAL SYNDROME 830 0.0094
435 MUSCULOSKELETAL CHEST PAIN 146 0.0094
436 HEART RATE INCREASED 934 0.0094
437 PHOTOPHOBIA 177 0.0094
438 PALPITATIONS 1099 0.0094
439 VENTRICULAR FIBRILLATION 104 0.0094
440 DIPLOPIA 243 0.0093
441 BACK PAIN 2172 0.0093
442 WRIST FRACTURE 112 0.0093
443 PHARYNGITIS STREPTOCOCCAL 101 0.0093
444 TOOTH ABSCESS 95 0.0093
445 SURGERY 546 0.0093
446 BURNING SENSATION 652 0.0093
447 WEIGHT DECREASED 2593 0.0093
448 MUSCLE SPASTICITY 114 0.0093
449 DYSURIA 341 0.0093
450 FATIGUE 7210 0.0093
451 DYSGEUSIA 687 0.0092
452 MADAROSIS 107 0.0092
453 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 158 0.0092
454 PANCREATITIS 487 0.0092
455 OVERDOSE 1987 0.0092
456 HIP ARTHROPLASTY 141 0.0092
457 SUPRAVENTRICULAR TACHYCARDIA 88 0.0092
458 TOOTH INFECTION 121 0.0092
459 JOINT RANGE OF MOTION DECREASED 123 0.0092
460 VISUAL FIELD DEFECT 66 0.0091
461 TACHYCARDIA 811 0.0091
462 MOTOR DYSFUNCTION 93 0.0091
463 DISCOMFORT 556 0.0091
464 SPINAL OPERATION 112 0.0091
465 MOBILITY DECREASED 653 0.0091
466 DECREASED ACTIVITY 98 0.0091
467 NERVE INJURY 101 0.0091
468 COLD SWEAT 160 0.0091
469 MUSCULOSKELETAL DISCOMFORT 156 0.0091
470 INTENTIONAL PRODUCT MISUSE 793 0.0090
471 EYE MOVEMENT DISORDER 62 0.0090
472 NEPHROLITHIASIS 415 0.0090
473 JOINT INJURY 193 0.0090
474 BLOOD PRESSURE INCREASED 1380 0.0090
475 URTICARIA 1507 0.0090
476 TENDONITIS 139 0.0090
477 DIZZINESS POSTURAL 87 0.0090
478 HYPERGLYCAEMIA 325 0.0089
479 POISONING 112 0.0089
480 UNRESPONSIVE TO STIMULI 230 0.0089
481 GASTROINTESTINAL PAIN 98 0.0089
482 PHARYNGEAL OEDEMA 137 0.0089
483 PARAESTHESIA 1400 0.0089
484 PSORIATIC ARTHROPATHY 361 0.0089
485 ANAL INCONTINENCE 80 0.0089
486 BLOOD POTASSIUM DECREASED 267 0.0089
487 UTERINE PERFORATION 75 0.0089
488 DYSPEPSIA 871 0.0088
489 FOREIGN BODY IN REPRODUCTIVE TRACT 79 0.0088
490 OVARIAN CYST 88 0.0088
491 NASAL CONGESTION 517 0.0088
492 GROIN PAIN 77 0.0088
493 CHEST PAIN 1621 0.0087
494 GRIP STRENGTH DECREASED 77 0.0087
495 ILL-DEFINED DISORDER 530 0.0087
496 LOCAL SWELLING 152 0.0087
497 PAIN 5343 0.0087
498 MOUTH ULCERATION 183 0.0087
499 PSORIASIS 1134 0.0087
500 ATAXIA 103 0.0087
501 NEPHROPATHY 81 0.0087
502 BEDRIDDEN 114 0.0087
503 CONDITION AGGRAVATED 2637 0.0087
504 MEDICATION ERROR 482 0.0087
505 KIDNEY INFECTION 170 0.0087
506 CARDIO-RESPIRATORY ARREST 362 0.0086
507 LOW DENSITY LIPOPROTEIN INCREASED 67 0.0086
508 HOT FLUSH 652 0.0086
509 CONTUSION 832 0.0086
510 INFLUENZA LIKE ILLNESS 711 0.0086
511 BONE DISORDER 157 0.0086
512 HAEMORRHOIDS 168 0.0086
513 GAIT DISTURBANCE 1647 0.0086
514 POOR VENOUS ACCESS 89 0.0086
515 FEELING HOT 527 0.0086
516 BLOOD SODIUM DECREASED 162 0.0086
517 RENAL FAILURE CHRONIC 66 0.0086
518 FLUSHING 871 0.0086
519 INTENTIONAL DRUG MISUSE 179 0.0086
520 SKIN INFECTION 96 0.0085
521 WHEEZING 507 0.0085
522 CHRONIC KIDNEY DISEASE 648 0.0085
523 INTENTIONAL DOSE OMISSION 243 0.0085
524 HAEMATOCRIT DECREASED 169 0.0085
525 FALL 2834 0.0085
526 APHTHOUS ULCER 66 0.0085
527 MITRAL VALVE INCOMPETENCE 96 0.0085
528 BODY TEMPERATURE INCREASED 173 0.0085
529 MULTIPLE SCLEROSIS 405 0.0085
530 DRUG EFFECT DECREASED 456 0.0085
531 PHARYNGITIS 105 0.0085
532 SMALL INTESTINAL OBSTRUCTION 104 0.0084
533 PERIPHERAL COLDNESS 116 0.0084
534 ULCER 134 0.0084
535 PRODUCT DOSE OMISSION IN ERROR 238 0.0084
536 RENAL DISORDER 391 0.0084
537 CORONARY ARTERY DISEASE 254 0.0084
538 HEREDITARY ANGIOEDEMA 90 0.0084
539 ADVERSE DRUG REACTION 753 0.0084
540 ACIDOSIS 64 0.0084
541 ABDOMINAL DISCOMFORT 1399 0.0083
542 CYST 103 0.0083
543 PAIN IN JAW 235 0.0083
544 ABORTION SPONTANEOUS 332 0.0083
545 ADVERSE EVENT 763 0.0083
546 LOWER LIMB FRACTURE 159 0.0083
547 URINARY RETENTION 275 0.0082
548 BREAST TENDERNESS 62 0.0082
549 DISEASE RECURRENCE 390 0.0082
550 HYPOKINESIA 119 0.0082
551 CELLULITIS 413 0.0082
552 ARTERIOSCLEROSIS 77 0.0082
553 INFECTION 1183 0.0082
554 GINGIVAL PAIN 65 0.0082
555 HYPOAESTHESIA ORAL 123 0.0082
556 THERAPEUTIC RESPONSE DECREASED 494 0.0081
557 HEART RATE IRREGULAR 184 0.0081
558 LIMB INJURY 221 0.0081
559 KNEE OPERATION 80 0.0081
560 PARAESTHESIA ORAL 117 0.0081
561 ORAL PAIN 181 0.0081
562 ABDOMINAL PAIN UPPER 1664 0.0081
563 OEDEMA PERIPHERAL 980 0.0080
564 THERAPY CHANGE 79 0.0080
565 MUSCLE SPASMS 1470 0.0080
566 EYE PAIN 449 0.0079
567 RASH 3463 0.0079
568 DYSPHAGIA 754 0.0079
569 GASTRITIS 209 0.0079
570 DEAFNESS 207 0.0079
571 GOUT 142 0.0079
572 UPPER LIMB FRACTURE 157 0.0079
573 LYMPHADENOPATHY 278 0.0078
574 IMPAIRED HEALING 257 0.0078
575 DYSSTASIA 228 0.0078
576 METRORRHAGIA 133 0.0078
577 FEEDING DISORDER 158 0.0078
578 DEHYDRATION 1039 0.0078
579 DIABETIC KETOACIDOSIS 187 0.0078
580 THYROID DISORDER 120 0.0078
581 DRUG TOXICITY 106 0.0078
582 SCRATCH 82 0.0078
583 BLOOD MAGNESIUM DECREASED 67 0.0078
584 WOUND INFECTION 85 0.0078
585 DEPRESSED LEVEL OF CONSCIOUSNESS 307 0.0078
586 HERNIA 150 0.0077
587 ABDOMINAL PAIN 1804 0.0077
588 PRODUCT USE ISSUE 1457 0.0077
589 ABDOMINAL DISTENSION 808 0.0077
590 DRY EYE 385 0.0077
591 SPINAL DISORDER 73 0.0077
592 MALNUTRITION 86 0.0077
593 RESPIRATORY TRACT CONGESTION 122 0.0077
594 TRANSIENT ISCHAEMIC ATTACK 258 0.0076
595 CHEST DISCOMFORT 783 0.0076
596 HEAD DISCOMFORT 135 0.0076
597 TOOTH DISORDER 169 0.0076
598 EMOTIONAL DISTRESS 919 0.0076
599 MENORRHAGIA 149 0.0076
600 BLOOD IRON DECREASED 90 0.0076
601 DYSTONIA 147 0.0076
602 DYSMENORRHOEA 100 0.0075
603 PRODUCT TASTE ABNORMAL 102 0.0075
604 C-REACTIVE PROTEIN INCREASED 274 0.0075
605 OROPHARYNGEAL PAIN 696 0.0075
606 SENSATION OF FOREIGN BODY 63 0.0075
607 THERAPY NON-RESPONDER 335 0.0074
608 MOVEMENT DISORDER 238 0.0074
609 INJECTION SITE INDURATION 96 0.0074
610 DEEP VEIN THROMBOSIS 481 0.0074
611 ASPIRATION 81 0.0074
612 VOMITING 3472 0.0074
613 ORAL HERPES 144 0.0074
614 RASH GENERALISED 191 0.0074
615 UNEVALUABLE EVENT 558 0.0074
616 BASAL CELL CARCINOMA 115 0.0074
617 TOXICITY TO VARIOUS AGENTS 1239 0.0073
618 HEPATOMEGALY 72 0.0073
619 THROAT TIGHTNESS 198 0.0073
620 APHONIA 102 0.0073
621 THERAPY CESSATION 375 0.0073
622 CORONARY ARTERY OCCLUSION 100 0.0073
623 DRUG EFFECT LESS THAN EXPECTED 108 0.0073
624 DRUG INEFFECTIVE 9602 0.0073
625 FLATULENCE 413 0.0073
626 MULTIPLE SCLEROSIS RELAPSE 499 0.0073
627 MYALGIA 1235 0.0073
628 HEAVY MENSTRUAL BLEEDING 65 0.0072
629 PHOTOSENSITIVITY REACTION 119 0.0072
630 RESPIRATORY DISORDER 215 0.0072
631 OSTEOMYELITIS 130 0.0072
632 MATERNAL EXPOSURE DURING PREGNANCY 639 0.0072
633 OESOPHAGITIS 78 0.0071
634 BLOOD PRESSURE FLUCTUATION 171 0.0071
635 RESPIRATORY TRACT INFECTION 185 0.0071
636 ARTHRALGIA 2953 0.0071
637 RESPIRATORY RATE INCREASED 63 0.0071
638 SWOLLEN TONGUE 221 0.0071
639 LEUKOCYTOSIS 128 0.0071
640 HYPOKALAEMIA 326 0.0071
641 DECREASED APPETITE 1636 0.0070
642 IRON DEFICIENCY ANAEMIA 65 0.0070
643 PRODUCTIVE COUGH 336 0.0070
644 END STAGE RENAL DISEASE 128 0.0070
645 NEUROLEPTIC MALIGNANT SYNDROME 83 0.0070
646 ANKYLOSING SPONDYLITIS 92 0.0070
647 HYPOCALCAEMIA 132 0.0070
648 ABASIA 172 0.0070
649 PRESYNCOPE 169 0.0069
650 MUSCULAR WEAKNESS 789 0.0069
651 ERUCTATION 134 0.0069
652 PRODUCT QUALITY ISSUE 939 0.0069
653 ORAL CANDIDIASIS 91 0.0069
654 RASH PRURITIC 374 0.0069
655 MUSCULOSKELETAL PAIN 361 0.0069
656 URINARY TRACT INFECTION 1175 0.0069
657 CANDIDA INFECTION 116 0.0069
658 MALAISE 2992 0.0068
659 EJECTION FRACTION DECREASED 106 0.0068
660 INFLAMMATION 350 0.0068
661 FUNGAL INFECTION 226 0.0068
662 PULMONARY MASS 101 0.0068
663 SWELLING 634 0.0068
664 DYSPNOEA EXERTIONAL 254 0.0067
665 PROCEDURAL PAIN 187 0.0067
666 PAIN IN EXTREMITY 1981 0.0067
667 LIVER INJURY 165 0.0067
668 CARDIOMYOPATHY 99 0.0067
669 WHITE BLOOD CELL COUNT INCREASED 257 0.0067
670 MUSCLE RIGIDITY 80 0.0067
671 NASOPHARYNGITIS 1232 0.0067
672 OEDEMA 362 0.0067
673 COVID-19 1171 0.0067
674 POST PROCEDURAL COMPLICATION 128 0.0067
675 COUGH 1869 0.0067
676 DELIRIUM 231 0.0066
677 VITREOUS FLOATERS 65 0.0066
678 ASTHENIA 2484 0.0066
679 DYSPHONIA 386 0.0066
680 VISUAL IMPAIRMENT 817 0.0066
681 TOOTH EXTRACTION 82 0.0066
682 CARDIAC ARREST 543 0.0066
683 EYE SWELLING 244 0.0066
684 BLISTER 367 0.0065
685 THROAT IRRITATION 293 0.0065
686 PRODUCT AVAILABILITY ISSUE 148 0.0065
687 SALIVARY HYPERSECRETION 65 0.0065
688 QUALITY OF LIFE DECREASED 87 0.0065
689 NO THERAPEUTIC RESPONSE 79 0.0065
690 PULMONARY EMBOLISM 615 0.0065
691 SWELLING FACE 421 0.0065
692 ILLNESS 666 0.0065
693 GAIT INABILITY 216 0.0065
694 ACCIDENTAL OVERDOSE 236 0.0064
695 NEUROPATHY PERIPHERAL 613 0.0064
696 PHARYNGEAL SWELLING 63 0.0064
697 PANCREATITIS ACUTE 144 0.0064
698 VIRAL INFECTION 213 0.0064
699 FEELING COLD 178 0.0064
700 AMENORRHOEA 112 0.0064
701 VAGINAL HAEMORRHAGE 277 0.0064
702 GASTRIC DISORDER 219 0.0064
703 HEPATITIS 163 0.0064
704 EYE DISCHARGE 66 0.0063
705 STOMATITIS 382 0.0063
706 IMMUNE SYSTEM DISORDER 83 0.0063
707 DRY THROAT 64 0.0063
708 HERPES ZOSTER 361 0.0063
709 TENDON RUPTURE 77 0.0062
710 INFLUENZA 695 0.0062
711 DRUG DISPENSING ERROR 95 0.0062
712 ABDOMINAL PAIN LOWER 157 0.0062
713 VASCULITIS 72 0.0062
714 PRURITUS 2370 0.0062
715 HYPOTENSION 1236 0.0062
716 PRODUCT USE IN UNAPPROVED INDICATION 1527 0.0062
717 RHINORRHOEA 398 0.0062
718 HYPERCALCAEMIA 76 0.0061
719 HEMIPARESIS 104 0.0061
720 LOCALISED INFECTION 148 0.0061
721 BLOOD URINE PRESENT 116 0.0061
722 LYMPHOCYTE COUNT DECREASED 108 0.0061
723 ERYTHEMA 1254 0.0061
724 ASPARTATE AMINOTRANSFERASE INCREASED 324 0.0061
725 CHILLS 714 0.0061
726 ORTHOSTATIC HYPOTENSION 106 0.0061
727 BLOOD PRESSURE ABNORMAL 121 0.0061
728 PNEUMONIA ASPIRATION 152 0.0061
729 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 332 0.0060
730 SPINAL FRACTURE 121 0.0060
731 COMPLICATION OF DEVICE REMOVAL 109 0.0060
732 ACCIDENT 72 0.0060
733 GASTROINTESTINAL DISORDER 539 0.0060
734 MASS 84 0.0060
735 CARDIAC DISORDER 559 0.0060
736 SPINAL PAIN 70 0.0060
737 ELECTROLYTE IMBALANCE 69 0.0059
738 PNEUMONIA 1915 0.0059
739 CATARACT 352 0.0059
740 DRUG ABUSE 492 0.0059
741 INJECTION SITE NODULE 65 0.0059
742 SKIN LESION 162 0.0059
743 MUSCULOSKELETAL DISORDER 112 0.0059
744 CIRCULATORY COLLAPSE 100 0.0059
745 INJECTION SITE REACTION 399 0.0058
746 DYSPNOEA 3279 0.0058
747 PRURITUS GENERALISED 125 0.0058
748 OXYGEN SATURATION DECREASED 324 0.0058
749 MUSCLE ATROPHY 73 0.0058
750 THERAPEUTIC RESPONSE SHORTENED 191 0.0058
751 PRODUCT DOSE OMISSION ISSUE 1693 0.0058
752 RASH PAPULAR 129 0.0057
753 ALANINE AMINOTRANSFERASE INCREASED 353 0.0057
754 BLOOD PRESSURE DECREASED 382 0.0057
755 RED BLOOD CELL COUNT DECREASED 164 0.0057
756 HYPOXIA 202 0.0057
757 HEART RATE DECREASED 201 0.0057
758 DIARRHOEA 3694 0.0057
759 CHOKING 111 0.0057
760 CENTRAL NERVOUS SYSTEM LESION 78 0.0057
761 ACUTE RESPIRATORY FAILURE 109 0.0057
762 DIVERTICULITIS 157 0.0057
763 HIP FRACTURE 182 0.0057
764 PARALYSIS 81 0.0057
765 SKIN ULCER 146 0.0056
766 MYOCARDIAL ISCHAEMIA 64 0.0056
767 OCULAR DISCOMFORT 63 0.0056
768 MALIGNANT MELANOMA 75 0.0056
769 INJECTION SITE MASS 207 0.0056
770 COMA 266 0.0056
771 EYE INFECTION 63 0.0056
772 GASTRIC ULCER 106 0.0056
773 PYREXIA 1929 0.0056
774 BLOOD ALKALINE PHOSPHATASE INCREASED 138 0.0056
775 AGEUSIA 138 0.0055
776 INJECTION SITE HAEMATOMA 80 0.0055
777 EYE DISORDER 181 0.0055
778 BONE PAIN 322 0.0055
779 LIP SWELLING 183 0.0055
780 COMPLICATION OF DEVICE INSERTION 109 0.0055
781 SKIN DISCOLOURATION 251 0.0055
782 RENAL FAILURE 723 0.0054
783 SCAB 62 0.0054
784 MULTIPLE FRACTURES 89 0.0054
785 GASTROENTERITIS 79 0.0054
786 HEPATITIS C 65 0.0054
787 BLOOD PRESSURE SYSTOLIC INCREASED 105 0.0054
788 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 383 0.0054
789 DRUG PRESCRIBING ERROR 103 0.0054
790 RENAL INJURY 159 0.0053
791 PERIPHERAL SWELLING 821 0.0053
792 PULMONARY HYPERTENSION 111 0.0053
793 ABSCESS 85 0.0053
794 OFF LABEL USE 4613 0.0053
795 MENSTRUATION IRREGULAR 141 0.0053
796 TOOTH LOSS 109 0.0053
797 RECTAL HAEMORRHAGE 224 0.0052
798 SYNCOPE 521 0.0052
799 BLOOD UREA INCREASED 87 0.0052
800 ORAL DISCOMFORT 72 0.0052
801 TASTE DISORDER 105 0.0052
802 INTESTINAL OBSTRUCTION 195 0.0052
803 STEVENS-JOHNSON SYNDROME 115 0.0052
804 SNEEZING 116 0.0052
805 HYPOGLYCAEMIA 247 0.0051
806 DRUG DOSE OMISSION 841 0.0051
807 CLOSTRIDIUM DIFFICILE INFECTION 111 0.0051
808 SKIN HAEMORRHAGE 75 0.0051
809 SOPOR 67 0.0051
810 CARDIAC FAILURE CONGESTIVE 406 0.0050
811 COMPLICATION ASSOCIATED WITH DEVICE 73 0.0050
812 HYPOPHAGIA 128 0.0050
813 PULMONARY CONGESTION 66 0.0050
814 PREGNANCY 100 0.0050
815 PNEUMOTHORAX 79 0.0050
816 ADVERSE REACTION 66 0.0050
817 METABOLIC ACIDOSIS 159 0.0050
818 THROMBOCYTOPENIA 556 0.0050
819 MYOCARDIAL INFARCTION 867 0.0050
820 GENERAL PHYSICAL HEALTH DETERIORATION 575 0.0050
821 ANGINA PECTORIS 142 0.0050
822 PLATELET COUNT INCREASED 64 0.0049
823 PRODUCT PHYSICAL ISSUE 99 0.0049
824 VISUAL ACUITY REDUCED 163 0.0049
825 RESPIRATORY ARREST 135 0.0049
826 PRODUCT USE COMPLAINT 77 0.0049
827 SKIN DISORDER 163 0.0049
828 GLAUCOMA 94 0.0049
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 878 0.0049
830 PLEURAL EFFUSION 296 0.0049
831 CONJUNCTIVITIS 90 0.0048
832 ARRHYTHMIA 229 0.0048
833 INJECTION SITE URTICARIA 118 0.0048
834 NERVOUS SYSTEM DISORDER 150 0.0048
835 EYE IRRITATION 274 0.0048
836 SKIN FISSURES 93 0.0048
837 DRUG ERUPTION 84 0.0047
838 FREQUENT BOWEL MOVEMENTS 128 0.0047
839 DERMATITIS ATOPIC 249 0.0047
840 RASH MACULAR 164 0.0047
841 EXTRAPYRAMIDAL DISORDER 116 0.0047
842 LACRIMATION INCREASED 141 0.0047
843 THERAPY INTERRUPTED 332 0.0046
844 BLOOD GLUCOSE DECREASED 223 0.0046
845 HAEMATOCHEZIA 256 0.0046
846 ANOSMIA 67 0.0046
847 BRADYCARDIA 245 0.0046
848 DEMENTIA 129 0.0046
849 LIVER FUNCTION TEST ABNORMAL 134 0.0046
850 APPLICATION SITE ERYTHEMA 120 0.0046
851 INJECTION SITE PRURITUS 306 0.0046
852 BACTERIAL INFECTION 85 0.0046
853 BLOOD COUNT ABNORMAL 69 0.0045
854 DRUG EFFECT INCOMPLETE 165 0.0045
855 THROMBOSIS 364 0.0045
856 COLITIS ULCERATIVE 202 0.0045
857 EYE PRURITUS 151 0.0045
858 DEVICE DISLOCATION 195 0.0045
859 EPILEPSY 137 0.0045
860 ACUTE MYOCARDIAL INFARCTION 132 0.0045
861 CHROMATURIA 101 0.0045
862 INJECTION SITE WARMTH 92 0.0045
863 PRODUCT DOSE OMISSION 289 0.0044
864 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 894 0.0044
865 DEVICE BREAKAGE 178 0.0044
866 ANAPHYLACTIC REACTION 241 0.0044
867 FAECES DISCOLOURED 94 0.0043
868 DRUG-INDUCED LIVER INJURY 136 0.0043
869 UNDERDOSE 316 0.0043
870 INJECTION SITE BRUISING 344 0.0043
871 LABORATORY TEST ABNORMAL 127 0.0043
872 DRUG LEVEL INCREASED 71 0.0043
873 PRODUCT PRESCRIBING ERROR 102 0.0043
874 INCORRECT DRUG ADMINISTRATION DURATION 120 0.0043
875 LOWER RESPIRATORY TRACT INFECTION 194 0.0043
876 BLOOD CREATININE INCREASED 278 0.0043
877 DRUG WITHDRAWAL SYNDROME NEONATAL 63 0.0043
878 HOSPITALISATION 650 0.0042
879 INJECTION SITE PAIN 1296 0.0042
880 EPISTAXIS 313 0.0042
881 SEPTIC SHOCK 182 0.0042
882 DERMATITIS 87 0.0041
883 HAEMOPTYSIS 115 0.0041
884 GLYCOSYLATED HAEMOGLOBIN INCREASED 104 0.0041
885 BLINDNESS 167 0.0041
886 INJECTION SITE ERYTHEMA 505 0.0041
887 CYANOSIS 64 0.0041
888 HYPONATRAEMIA 229 0.0041
889 BLOOD POTASSIUM INCREASED 66 0.0041
890 PAIN OF SKIN 109 0.0040
891 PRODUCT DISPENSING ERROR 88 0.0040
892 RHABDOMYOLYSIS 168 0.0040
893 RESPIRATORY DISTRESS 111 0.0040
894 LUNG DISORDER 197 0.0040
895 NEEDLE ISSUE 117 0.0040
896 APPLICATION SITE PRURITUS 91 0.0040
897 COLITIS 152 0.0040
898 CEREBROVASCULAR ACCIDENT 679 0.0040
899 PROTEINURIA 76 0.0040
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 115 0.0040
901 BONE DENSITY DECREASED 124 0.0040
902 BLOOD GLUCOSE ABNORMAL 73 0.0039
903 RENAL FAILURE ACUTE 167 0.0039
904 HAEMOGLOBIN DECREASED 403 0.0039
905 FOETAL EXPOSURE DURING PREGNANCY 319 0.0039
906 PRODUCT ADHESION ISSUE 140 0.0039
907 PRODUCT PREPARATION ERROR 80 0.0039
908 FEMUR FRACTURE 120 0.0039
909 ANAEMIA 739 0.0039
910 FULL BLOOD COUNT DECREASED 77 0.0038
911 ACNE 287 0.0038
912 APPLICATION SITE PAIN 83 0.0038
913 INJECTION SITE RASH 115 0.0037
914 INJECTION SITE SWELLING 287 0.0037
915 HAEMATOMA 97 0.0037
916 WHITE BLOOD CELL COUNT DECREASED 404 0.0037
917 PALLOR 101 0.0037
918 PULMONARY OEDEMA 166 0.0037
919 DRY SKIN 494 0.0037
920 INCORRECT DOSE ADMINISTERED 838 0.0037
921 HAEMATEMESIS 93 0.0037
922 ACUTE KIDNEY INJURY 555 0.0036
923 ACUTE RESPIRATORY DISTRESS SYNDROME 64 0.0036
924 ECZEMA 188 0.0036
925 SEPSIS 400 0.0036
926 PRODUCT PRESCRIBING ISSUE 78 0.0036
927 PRODUCT ADMINISTRATION ERROR 72 0.0036
928 OCULAR HYPERAEMIA 168 0.0035
929 ATRIAL FIBRILLATION 344 0.0035
930 TUBULOINTERSTITIAL NEPHRITIS 66 0.0035
931 SKIN EXFOLIATION 294 0.0035
932 RENAL IMPAIRMENT 289 0.0034
933 BLOOD GLUCOSE INCREASED 648 0.0034
934 OSTEONECROSIS OF JAW 85 0.0034
935 RESPIRATORY FAILURE 246 0.0034
936 HYPOACUSIS 145 0.0034
937 LEUKOPENIA 168 0.0034
938 INJECTION SITE HAEMORRHAGE 266 0.0033
939 HAEMATURIA 111 0.0032
940 LIVER FUNCTION TEST INCREASED 69 0.0032
941 EXTRA DOSE ADMINISTERED 130 0.0032
942 LIVER DISORDER 142 0.0032
943 GYNAECOMASTIA 99 0.0032
944 PREMATURE BABY 96 0.0032
945 EXPIRED PRODUCT ADMINISTERED 106 0.0032
946 OSTEONECROSIS 104 0.0032
947 INCORRECT ROUTE OF DRUG ADMINISTRATION 112 0.0031
948 BLOOD BILIRUBIN INCREASED 81 0.0030
949 DEVICE MALFUNCTION 208 0.0030
950 INCORRECT PRODUCT ADMINISTRATION DURATION 64 0.0030
951 DEVICE EXPULSION 189 0.0029
952 DEVICE ISSUE 259 0.0029
953 PERICARDIAL EFFUSION 66 0.0029
954 CARDIOVASCULAR DISORDER 70 0.0028
955 PNEUMONITIS 75 0.0028
956 EXPOSURE VIA SKIN CONTACT 69 0.0027
957 PLATELET COUNT DECREASED 283 0.0027
958 SKIN IRRITATION 121 0.0026
959 DRUG DEPENDENCE 422 0.0026
960 ASCITES 75 0.0025
961 GASTROINTESTINAL HAEMORRHAGE 213 0.0025
962 HEPATIC FAILURE 76 0.0025
963 HAEMORRHAGE 262 0.0025
964 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
965 ANAPHYLACTIC SHOCK 64 0.0025
966 BREAST CANCER FEMALE 66 0.0025
967 PRODUCT COMPLAINT 62 0.0024
968 INTERSTITIAL LUNG DISEASE 117 0.0024
969 SKIN BURNING SENSATION 172 0.0024
970 JAUNDICE 63 0.0023
971 ANGIOEDEMA 100 0.0023
972 NEOPLASM MALIGNANT 150 0.0022
973 NEUTROPHIL COUNT DECREASED 91 0.0022
974 NO ADVERSE EVENT 397 0.0022
975 LUNG NEOPLASM MALIGNANT 88 0.0021
976 NEOPLASM PROGRESSION 74 0.0021
977 CARDIAC FAILURE 164 0.0020
978 HYPERKALAEMIA 68 0.0019
979 CEREBRAL HAEMORRHAGE 69 0.0019
980 PANCYTOPENIA 102 0.0018
981 ACCIDENTAL EXPOSURE TO PRODUCT 183 0.0018
982 PLASMA CELL MYELOMA 67 0.0017
983 DEVICE LEAKAGE 73 0.0017
984 BREAST CANCER 152 0.0016
985 DISEASE PROGRESSION 188 0.0016
986 DEATH 1164 0.0013
987 PRODUCT STORAGE ERROR 118 0.0013
988 DEPENDENCE 73 0.0013
989 NEUTROPENIA 163 0.0012
990 FEBRILE NEUTROPENIA 78 0.0012
991 MALIGNANT NEOPLASM PROGRESSION 106 0.0010
992 DEVICE DIFFICULT TO USE 62 0.0009